Compare Abbott India with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TTK HEALTHCARE - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA TTK HEALTHCARE ABBOTT INDIA/
TTK HEALTHCARE
 
P/E (TTM) x 43.1 18.3 236.3% View Chart
P/BV x 12.4 1.5 845.3% View Chart
Dividend Yield % 0.6 1.1 52.9%  

Financials

 ABBOTT INDIA   TTK HEALTHCARE
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
TTK HEALTHCARE
Mar-19
ABBOTT INDIA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs6,1101,215 502.9%   
Low Rs3,996610 655.0%   
Sales per share (Unadj.) Rs1,552.2444.4 349.3%  
Earnings per share (Unadj.) Rs188.817.2 1,094.7%  
Cash flow per share (Unadj.) Rs196.427.6 710.9%  
Dividends per share (Unadj.) Rs55.005.00 1,100.0%  
Dividend yield (eoy) %1.10.5 198.7%  
Book value per share (Unadj.) Rs796.6177.9 447.7%  
Shares outstanding (eoy) m21.2514.13 150.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.1 158.5%   
Avg P/E ratio x26.852.9 50.6%  
P/CF ratio (eoy) x25.733.0 77.9%  
Price / Book Value ratio x6.35.1 123.7%  
Dividend payout %29.129.0 100.5%   
Avg Mkt Cap Rs m107,37612,894 832.7%   
No. of employees `0003.32.3 143.7%   
Total wages/salary Rs m3,9371,307 301.2%   
Avg. sales/employee Rs Th9,929.32,715.7 365.6%   
Avg. wages/employee Rs Th1,185.1565.3 209.6%   
Avg. net profit/employee Rs Th1,207.7105.4 1,145.8%   
INCOME DATA
Net Sales Rs m32,9856,279 525.3%  
Other income Rs m1,17078 1,509.5%   
Total revenues Rs m34,1556,356 537.3%   
Gross profit Rs m5,245496 1,058.3%  
Depreciation Rs m162147 110.4%   
Interest Rs m3834 113.0%   
Profit before tax Rs m6,215393 1,583.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203149 1,479.3%   
Profit after tax Rs m4,012244 1,646.3%  
Gross profit margin %15.97.9 201.5%  
Effective tax rate %35.437.9 93.5%   
Net profit margin %12.23.9 313.4%  
BALANCE SHEET DATA
Current assets Rs m22,6552,717 833.8%   
Current liabilities Rs m6,6811,571 425.3%   
Net working cap to sales %48.418.3 265.2%  
Current ratio x3.41.7 196.0%  
Inventory Days Days6532 201.4%  
Debtors Days Days2947 62.5%  
Net fixed assets Rs m835991 84.3%   
Share capital Rs m213141 150.4%   
"Free" reserves Rs m16,7152,373 704.4%   
Net worth Rs m16,9282,514 673.3%   
Long term debt Rs m03 0.0%   
Total assets Rs m24,1624,158 581.1%  
Interest coverage x163.712.6 1,297.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.41.5 90.4%   
Return on assets %16.86.7 251.2%  
Return on equity %23.79.7 244.5%  
Return on capital %36.916.9 218.1%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m369225 163.7%   
Fx outflow Rs m3,80771 5,353.1%   
Net fx Rs m-3,438154 -2,231.2%   
CASH FLOW
From Operations Rs m1,527173 882.1%  
From Investments Rs m-2,14897 -2,226.3%  
From Financial Activity Rs m-1,024-307 333.3%  
Net Cashflow Rs m-1,646-38 4,365.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.7 213.5%  
FIIs % 0.1 5.2 1.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 25.8 66.3%  
Shareholders   18,270 12,723 143.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Sep 13, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS